Opportunity Information: Apply for RFA AG 25 031

The National Institutes of Health (NIH), through the National Institute on Aging (NIA), is offering a small research grant opportunity designed specifically to help build the next generation of aging and Alzheimer’s research leaders in low- and middle-income countries (LMICs). The funding announcement is titled "Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) Research" and it uses the NIH R03 mechanism, meaning it is intended for small, focused projects that can generate early results and position investigators for larger future studies. Clinical trials are not allowed under this opportunity, so projects should be structured as non-trial research (for example, observational studies, secondary data analyses, pilot methods development, feasibility work that does not meet the NIH definition of a clinical trial, and other foundational research efforts).

At its core, the program has two main goals. First, it aims to support junior faculty investigators from LMICs so they can conduct aging, AD, and/or ADRD research within their own LMIC settings. The emphasis on doing the work in-country matters because it encourages research that is directly relevant to local populations, health systems, cultures, and real-world constraints, rather than simply extending findings from high-income settings. Second, it is explicitly meant to support career development, helping early-stage investigators in LMICs gain the experience, preliminary data, and professional momentum needed to become long-term leaders in aging and dementia research. The NIA signals that applicants should also think carefully about their research environment and mentorship or support structures, since the broader intent is not only to complete a small project but to strengthen the investigator’s trajectory and capacity for sustained research contributions.

The NOFO encourages applications that produce pilot data, resources, and practical research experience that can serve as a springboard for larger subsequent studies in aging, Alzheimer’s disease, and related dementias. In practice, this often means designing a project that answers a narrow, high-value question or tests a workable approach that can later be expanded. Examples of outputs that fit this intent include preliminary datasets, validated tools or measures for local use, early evidence supporting a hypothesis worth scaling, or proof that recruitment, data collection, specimen handling, or analytic pipelines can function effectively in the LMIC context. The overall theme is feasibility and foundation-building, not large-scale definitive testing.

Eligibility is broad in terms of institution types, but the opportunity is explicitly focused on proposals submitted from LMIC institutions as defined by World Bank classifications. The eligible applicant categories listed include many common U.S. governmental and organizational entity types (such as state, county, city, and special district governments; public and private institutions of higher education; nonprofit and for-profit organizations; small businesses; independent school districts; and tribal governments and organizations). The announcement also highlights several institution types and community-facing organizations as eligible, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and eligible federal agencies. Importantly, non-U.S. entities (foreign organizations) are eligible to apply, aligning with the program’s LMIC-centered purpose. At the same time, it clarifies an important boundary: non-domestic (non-U.S.) components of U.S. organizations are not eligible to apply as the applicant organization under this NOFO. Foreign components, as NIH defines them in the NIH Grants Policy Statement, are allowed, meaning collaborations that include foreign components can be appropriate, but the applicant structure must follow NIH’s rules as stated.

Key administrative details provided include the funding opportunity number RFA-AG-25-031, the activity category Health, and the CFDA number 93.866. The award ceiling is listed as $100,000, consistent with the R03 mechanism’s role as a small grant intended for targeted, early-stage work rather than large multi-year programs. The original closing date is February 14, 2025, and the opportunity was created on September 6, 2024. Taken together, the announcement is best understood as an NIA effort to strengthen dementia and aging research capacity in LMICs by giving junior faculty a manageable, career-building research award that produces credible pilot evidence and positions them to compete for larger NIH or other international research funding in the future.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimers Disease (AD) and AD-Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2024-09-06.
  • Applicants must submit their applications by 2025-02-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $100,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AG 25 031

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Alzheimers Disease Research

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: U.S.-Danish Floating Offshore Wind Energy Mooring and Anchoring Research and Development

Previous opportunity: NIJ FY24 Invited to Apply - Forensic Technology Center of Excellence (FTCOE)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AG 25 031

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AG 25 031) also looked into and applied for these:

Funding Opportunity
State-based Healthcare Extension Cooperatives to Accelerate Implementation of Actionable Knowledge into Practice (U19) Apply for RFA HS 24 004

Funding Number: RFA HS 24 004
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Trial Not Allowed) Apply for RFA DE 25 001

Funding Number: RFA DE 25 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial Not Allowed) Apply for RFA DE 25 002

Funding Number: RFA DE 25 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
RFI for SOPHI Apply for RFI 442 24 006

Funding Number: RFI 442 24 006
Agency: Cambodia USAID-Phnom Penh
Category: Health
Funding Amount: $35,000,000
Emergency Department Substance Use Surveillance System Apply for EDS EDS 24 001

Funding Number: EDS EDS 24 001
Agency: Office of National Drug Control Policy
Category: Health
Funding Amount: $150,000
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 24 275

Funding Number: PAR 24 275
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Coordinating Center to Support Consortium for Neuroscience Alzheimers Disease (AD) and AD-Related Dementias (ADRD) Research in Low- and Middle-Income Countries (LMICs) (U24 Clinical Trial Not Allowed) Apply for RFA AG 25 014

Funding Number: RFA AG 25 014
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Health Systems Strengthening (HSS) Activity Apply for 72038624RFA00004

Funding Number: 72038624RFA00004
Agency: India USAID-New Delhi
Category: Health
Funding Amount: $20,000,000
Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional) Apply for RFA MD 24 012

Funding Number: RFA MD 24 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
USAID Accelerator Activity Apply for 72066024RFA00006

Funding Number: 72066024RFA00006
Agency: Democratic Republic of the Congo USAID-Kinshasa
Category: Health
Funding Amount: $90,500,000
USAID Multi Sector Nutrition in the Democractic Republic of Congo Apply for 72066024RFI00007

Funding Number: 72066024RFI00007
Agency: Agency for International Development
Category: Health
Funding Amount: Case Dependent
Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional) Apply for RFA MH 25 200

Funding Number: RFA MH 25 200
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Discovery and Development of Novel Therapeutics for Select Fungal Pathogens (R21/R33 Clinical Trial Not Allowed) Apply for RFA AI 24 065

Funding Number: RFA AI 24 065
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
National Coordinating Center (NCC) for AHRQs Healthcare Extension Service - State-based Solutions to Healthcare Improvement (U54) Apply for RFA HS 24 006

Funding Number: RFA HS 24 006
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) Apply for RFA NS 25 024

Funding Number: RFA NS 25 024
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
National Evaluation Center (NEC) for AHRQs Healthcare Extension Service: State-based Solutions to Healthcare Improvement (U19) Apply for RFA HS 24 005

Funding Number: RFA HS 24 005
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Global Health Security (GHS) Activity Apply for 72039124RFA00002

Funding Number: 72039124RFA00002
Agency: Pakistan USAID-Islamabad
Category: Health
Funding Amount: $43,000,000
Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 25 061

Funding Number: PAR 25 061
Agency: National Institutes of Health
Category: Health
Funding Amount: $8,000,000
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) Apply for PAR 25 055

Funding Number: PAR 25 055
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed) Apply for PAR 25 020

Funding Number: PAR 25 020
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 25 031", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: